公开(公告)号：EP4144413A1

公开(公告)日：2023-03-08

申请号：EP21779174.8

申请日：2021-03-30

申请人： AJINOMOTO CO., INC.

发明人： SUSA, Yuko ,  ICHIKAWA, Reiko ,  INOUE, Yoshiko ,  TANAKA, Chie ,  SUZUKI, Katsuya

IPC分类号： A61P19/00 ,  A61P19/10 ,  A23L33/175 ,  A61K31/198

摘要： An object of the present invention is to provide a composition effective for preventing or improving bone strength decrease.
A composition for preventing or improving bone strength decrease (e.g., bone strength decrease due to bone density decrease, bone quality decrease, bone metabolism decrease, and the like), containing ornithine as an active ingredient.

公开(公告)号：EP4129409A1

公开(公告)日：2023-02-08

申请号：EP21776556.9

申请日：2021-03-25

申请人： AJINOMOTO CO., INC.

发明人： KATAYAMA, Yukino ,  SUZUKI, Kana ,  SUZUKI, Katsuya ,  TANAKA, Chie ,  TAKINO, Yoshinobu ,  SUGA, Yasuyo ,  ICHIKAWA, Reiko ,  AKIYOSHI, Shinobu

IPC分类号： A61P43/00 ,  A61P17/14 ,  A61Q7/00 ,  A23L33/175 ,  A61K8/44 ,  A61K8/49 ,  A61K31/198 ,  A61K31/405

摘要： According to the present invention, a composition that has high safety, can be continuously used for a long period, promotes production of VEGF and FGF7 involved in hair growth, and affords good prophylactic or improving effect on thinning hair or hair loss can be provided.
The present invention relates to a composition for promoting hair thickening, containing one or more members selected from the group consisting of citrulline, tryptophan, glutamine, and ornithine, a composition for maintaining the anagen phase in the hair cycle and a composition for promoting VEGF production, each containing one or more members selected from the group consisting of citrulline, tryptophan, and glutamine, a composition for promoting transition from the telogen phase to the anagen phase in the hair cycle and a composition for promoting FGF7 production, each containing ornithine, and a composition for promoting normalization of the hair cycle, containing one or more members selected from the group consisting of citrulline, tryptophan, glutamine, and ornithine.

公开(公告)号：EP3763363A1

公开(公告)日：2021-01-13

申请号：EP19764416.4

申请日：2019-03-05

申请人： AJINOMOTO CO., INC.

发明人： SATO, Hideaki ,  YASUI, Masako ,  ADACHI, Yusuke ,  SUZUKI, Katsuya ,  TAKADA, Michihiro

IPC分类号： A61K31/198 ,  A23L33/175 ,  A61K31/405 ,  A61K31/4172 ,  A61P25/22 ,  A61P25/28

摘要： The present invention provides a composition for improving cognitive function, a composition for improving anxiety-like symptoms, and a composition for suppressing cerebral atrophy containing one or more kinds selected from the group consisting of 25 mol% - 45 mol% of leucine, and 20 mol% - 40 mol% of phenylalanine relative to the total content of leucine, lysine, valine, isoleucine, phenylalanine, histidine and tryptophan, which are highly safe and can be ingested or administered continuously.

公开(公告)号：EP1935419A1

公开(公告)日：2008-06-25

申请号：EP06798165.4

申请日：2006-09-14

申请人： Ajinomoto Co., Inc.

发明人： KATSUDA, Shin-ichiro ,  HAZAMA, Akihiro ,  KOYAMA, Naoto ,  SUZUKI, Katsuya

IPC分类号： A61K31/4045 ,  A23L1/30 ,  A61K36/28 ,  A61P9/00 ,  A61P9/04 ,  A61P9/10 ,  A61P9/12 ,  C07D209/16

CPC分类号： C07D209/16 ,  A23L33/10 ,  A23L33/105 ,  A61K31/4045 ,  A61K36/28

摘要： The invention provides a novel agent for improving hemodynamics, which prevents or improves deterioration of hemodynamics associated with aging and progression of cardiovascular diseases. An agent for improving hemodynamics, which contains a serotonin derivative as an active ingredient.

摘要翻译： 本发明提供了用于改善血液动力学的新型药剂，其预防或改善与心血管疾病的老化和进展相关的血液动力学的恶化。 用于改善血液动力学的药剂，其含有5-羟色胺衍生物作为活性成分。